Carl Zeiss Meditec AG

AFX: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
@%LOCK|#SF#LOCK|<$&n@fJ

Carl Zeiss Earnings: Recovery Still Underway, but Lack of New Negatives Is Encouraging

Carl Zeiss delivered revenue growth of 2% and adjusted earnings per share growth of 29% for its fiscal third quarter. Both figures landed ahead of FactSet consensus.

Sponsor Center